Ed Urai / Getty images
With 10 vaccine candidates now in phase three trials, one expert predicts that another million people worldwide could die within three to six months.
One of these vaccine candidates is manufactured by Novavax. Dr. Gregory Glenn, head of research and development at Novavax, told NPR that he was not worried about policies that polluted the vaccine approval process.
As the world waits for a vaccine, NPR science reporter Michelle Ducklef reports a small but growing number of scientists are asking: what if we already have a vaccine that can slow the spread of the virus?
In the participating regions, you will also hear a local news segment that will help you understand what is happening in your community.
We are working on an upcoming pandemic precautionary episode and want to hear from you. Fill out the form on this page and we can track your response.
Send us an email at firstname.lastname@example.org.
This episode was produced by Brianna Scott, Lee Hale and Brent Baughman. Edited by Sammy Yenigun with the help of Win Davis, Scott Hensley and Rebecca Davis. Additional reporting by Joe Palka. Our executive producer is Kara Talo.